Jani Tirronen, Maculaser - Restoring Retinal Health | LSI Europe '24

Maculaser’s pioneering retinal treatment triggers the natural healing response of senescent cells with personalized heat exposure. Targeting disease prevention, we offer a patient-specific, non-damaging solution to retinal disorders affecting millions worldwide.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Jani Tirronen
Jani Tirronen
Co-Founder and CEO, Maculaser Oy